Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation
NCT00626626Phase 2Terminated
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- May 2007
- Primary completion
- Jan 2010
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in leukemia, myelodysplastic syndrome (MDS), lymphoma, multiple myeloma (MM), sponsored by Penn State Health Milton S. Hershey Medical Center. Started May 2007; status: terminated.
02
Drugs
clofarabine
03
Conditions
leukemiamyelodysplastic syndrome (MDS)lymphomamultiple myeloma (MM)
Beyond the preview
Go deeper on NCT00626626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626626.